Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06443905
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-05
First Post:
2024-04-26
Brief Title:
Xueshuantong Injection Lyophilized in the Prevention of Venous Thromboembolism VTE in Hospitalized Patients
Sponsor:
China-Japan Friendship Hospital
Organization:
China-Japan Friendship Hospital
Study Overview
Official Title:
Efficacy Safety and Cost-effectiveness of Xueshuantong Injection Lyophilized in the Prevention of Venous Thromboembolism VTE in Hospitalized Patients at Risk of Bleeding a Real-world Cohort Study
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to explore the efficacy safety and cost-effectiveness of Xueshuantong lyophilized for the prevention of venous thromboembolism VTE in patients at risk of bleeding
Detailed Description:
This is a non-randomized observational study
This study primarily aims to investigate the efficacy safety and cost-effectiveness of using Xueshuantong injection lyophilized for preventing venous thromboembolism VTE in patients susceptible to bleeding The subjects of the study comprise patients during the perioperative period undergoing procedures lasting 45 minutes or longer patients with a confirmed spontaneous cerebral hemorrhage ICH and patients with a confirmed acute ischemic stroke AIS
Additional objectives of this study including
1 to evaluate the possible dose-dependency of Xueshuantong injection lyophilized
2 to evaluate the impact in coagulation function after administration of Xueshuantong injection lyophilized
This study primarily aims to investigate the efficacy safety and cost-effectiveness of using Xueshuantong injection lyophilized for preventing venous thromboembolism VTE in patients susceptible to bleeding The subjects of the study comprise patients during the perioperative period undergoing procedures lasting 45 minutes or longer patients with a confirmed spontaneous cerebral hemorrhage ICH and patients with a confirmed acute ischemic stroke AIS
Additional objectives of this study including
1 to evaluate the possible dose-dependency of Xueshuantong injection lyophilized
2 to evaluate the impact in coagulation function after administration of Xueshuantong injection lyophilized
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None